Bacterial killing is enhanced by expression of lysozyme in the lungs of transgenic mice

Journal of Immunology

Volumn 165, Issue 10, 2000, Pages 5760-5766

  Akinbi, H T ^a   Epaud, R ^a   Bhatt, H ^a   Weaver, T E ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; LYSOZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME ACTIVITY; HOST RESISTANCE; IN VIVO STUDY; LUNG LAVAGE; LUNG STRUCTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY EPITHELIUM; STREPTOCOCCUS AGALACTIAE; SURVIVAL; TRANSGENIC MOUSE;

EID: 0034669924     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.10.5760     Document Type: Article

References (33)

1. Human lung lysozyme: Sources and properties
2. Vertebrate lysozymes
3. The role of extracellular bactericidal factors in pulmonary host defense
4. Activity of abundant antimicrobials of the human airway
5. Pulmonary lysozyme: A secretory protein of type II pneumocytes in the rat
6. Immunocytochemical localization of lysozymes in respiratory and other tissues
7. Evolution of rodent lysozymes: Isolation and sequence of the rat lysozyme genes
8. Mouse lysozyme M gene: Isolation, characterization, and expression studies
9. Recent origin of the P lysozyme gene in mice
10. Genetic element from human surfactant protein SP-C gene confers bronchiolar-alveolar cell specificity in transgenic mice
11. Transcriptional elements from the human SP-C gene direct expression in the primordial respiratory epithelium of transgenic mice
12. Human SP-C gene sequences that confer lung epithelium-specific expression in transgenic mice
13. Ablation of a critical surfactant protein B intramolecular disulfide bond in transgenic mice
14. Cis-acting sequences from a human surfactant protein gene confer pulmonary-specific gene expression in transgenic mice
15. Measurement of protein using bicinchoninic acid
16. Rescue of SP-B knockout mice with a truncated SP-B proprotein: Function of the C-terminal propeptide
17. Measurement of lysozyme activity and ultra-violet inactivation of lysozyme
18. Surfactant protein B (SP-B) -/- mice are rescued by restoration of SP-B expression in alveolar type II cells but not Clara cells
19. Altered surfactant protein B levels in transgenic mice do not affect clearance of bacteria from the lungs
20. Effect of human lysozyme on Gram-positive and Gram-negative bacteria
21. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface
22. Killing of Gram-negative bacteria by lactoferrin and lysozyme
23. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: Inhibition by chitin oligosaccharides
24. Bactericidal activities of lysozyme and aprotinin against Gram-negative and Gram-positive bacteria related to their basic character
25. The non-enzymatic microbicidal activity of lysozymes
26. Primary structure of rat lysozyme
27. Characterization and immunohistochemical localization of the 15 kD protein isolated from rat lung lamellar bodies
28. Immunocytochemical localization of lysozyme and surfactant protein-A in rat type-II cells and extracellular surfactant forms
29. Synthesis of type II cell lamellar body lysozyme 15 kD protein (lbl-15) by perfused rat lung
30. Surfactant protein A-deficient mice are susceptible to group streptococcal infection
31. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection
32. Surfactant protein A is localized at the corners of the pulmonary tubular myelin lattice
33. Aerosolized prolastin suppresses bacterial proliferation in a model of chronic pseudomonas aeruginosa lung infection